NDC 44087-4000

Mavenclad

Cladribine

Mavenclad is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Emd Serono, Inc.. The primary component is Cladribine.

Product ID44087-4000_673d345e-01f3-4692-b223-5f2199c1d78d
NDC44087-4000
Product TypeHuman Prescription Drug
Proprietary NameMavenclad
Generic NameCladribine
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2019-04-01
Marketing CategoryNDA / NDA
Application NumberNDA022561
Labeler NameEMD Serono, Inc.
Substance NameCLADRIBINE
Active Ingredient Strength10 mg/1
Pharm ClassesPurine Antimetabolite [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 44087-4000-0

5 BLISTER PACK in 1 CARTON (44087-4000-0) > 2 TABLET in 1 BLISTER PACK
Marketing Start Date2019-04-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 44087-4000-5 [44087400005]

Mavenclad TABLET
Marketing CategoryNDA
Application NumberNDA022561
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-04-01

NDC 44087-4000-9 [44087400009]

Mavenclad TABLET
Marketing CategoryNDA
Application NumberNDA022561
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-04-01

NDC 44087-4000-7 [44087400007]

Mavenclad TABLET
Marketing CategoryNDA
Application NumberNDA022561
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-04-01

NDC 44087-4000-6 [44087400006]

Mavenclad TABLET
Marketing CategoryNDA
Application NumberNDA022561
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-04-01

NDC 44087-4000-4 [44087400004]

Mavenclad TABLET
Marketing CategoryNDA
Application NumberNDA022561
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-04-01

NDC 44087-4000-0 [44087400000]

Mavenclad TABLET
Marketing CategoryNDA
Application NumberNDA022561
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-04-01

NDC 44087-4000-8 [44087400008]

Mavenclad TABLET
Marketing CategoryNDA
Application NumberNDA022561
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-04-01

Drug Details

Active Ingredients

IngredientStrength
CLADRIBINE10 mg/1

OpenFDA Data

SPL SET ID:9c75e30a-a410-40f1-b653-04d532bd9144
Manufacturer
UNII

Pharmacological Class

  • Purine Antimetabolite [EPC]
  • Purine Antimetabolite [EPC]

NDC Crossover Matching brand name "Mavenclad" or generic name "Cladribine"

NDCBrand NameGeneric Name
44087-4000MavencladCladribine
0143-9871CladribineCladribine
42658-010CladribineCladribine
63323-140CladribineCLADRIBINE
67457-450CladribineCladribine

Trademark Results [Mavenclad]

Mark Image

Registration | Serial
Company
Trademark
Application Date
MAVENCLAD
MAVENCLAD
79214141 5393708 Live/Registered
Merck KGaA
2017-05-19
MAVENCLAD
MAVENCLAD
79202778 5253420 Live/Registered
Merck KGaA
2017-01-18

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.